Dianne E. van der Wal: C-Terminal Endings Impact PAR1/PAR4 Peptide Potency in In Vitro Platelet Assays
Dianne E. van der Wal, Honorary Lecturer at the University of Sydney, Researcher at the ANZAC Research Institute, and Editor at Platelets journal, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in JTH, adding:
“Now in Journal of Thrombosis and Haemostasis (JTH)
When stimulating your platelets’ thrombin receptors in vitro, please be aware of the C-terminal ending of the PAR1/PAR4 peptides used
Their potency is very different in flow cytometry and light transmission aggregation assays.
New International Society on Thrombosis and Haemostasis (ISTH) SSC paper.”
Title: Impact of C-terminal amidation on platelet activation by PAR1 and PAR4 activating peptides: Communication from the ISTH SSC Subcommittee on Platelets in Health and Disease
Authors: Imane Boukhatem, Jessica Blais, Dianne E. van der Wal, Hanna Baloch, Tea Jerlström, Marie Lordkipanidzé, Sofia Ramström

More posts featuring Dianne E. van der Wal on Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines